Ionis Pharmaceuticals, Inc.
METHODS FOR REDUCING ATAXIN-2 EXPRESSION
Last updated:
Abstract:
Provided herein are methods for decreasing Ataxin-2 mRNA expression. Such methods are useful to ameliorate symptoms of Ataxin-2 associated diseases. Such Ataxin-2 associated diseases include amyotrophic lateral sclerosis (ALS). Such symptoms include loss of motor function, reduced CMAP amplitude, denervation, and loss of motor neurons.
Status:
Application
Type:
Utility
Filling date:
18 May 2021
Issue date:
26 May 2022